(Q34335217)

1 August 2017

1 reference

title

In vitro antifungal susceptibility testing (English)

1 reference

1 August 2017

Hoffman HL

1

1 reference

PubMed ID

11501985

1 August 2017

Pfaller MA

series ordinal

2

1 reference

PubMed ID

11501985

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

21

1 reference

1 August 2017

8 Pt 2

1 reference

1 August 2017

111S-123S

1 reference

Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach

1 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Evaluation of a colorimetric method for detecting amphotericin B-resistant Candida isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Etest for antifungal susceptibility testing of yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Antifungal susceptibility testing of yeasts: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Detection of amphotericin B-resistant Candida isolates in a broth-based system

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Antifungal susceptibility testing: technical advances and potential clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.12.111S.34510

10.1592/PHCO.21.12.111S.34510

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11501985